Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Mitobe

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Clinical Medicine Research|December 6, 2019
Skeletal Muscle Index at Intensive Care Unit Admission Is a Predictor of Intensive Care Unit-Acquired Weakness in Patients With SepsisYuta Mitobe, Shinichiro Morishita, Kazuki Ohashi, et al.
International Journal of Clinical Oncology|November 11, 2024
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resectionMasayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, et al.
Acta Neuropathologica Communications|October 1, 2024
Correction: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Japanese Journal of Clinical Oncology|September 3, 2024
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study groupKazuya Motomura, Keita Sasaki, Narushi Sugii, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Clinical Medicine Research|December 6, 2019
Skeletal Muscle Index at Intensive Care Unit Admission Is a Predictor of Intensive Care Unit-Acquired Weakness in Patients With SepsisYuta Mitobe, Shinichiro Morishita, Kazuki Ohashi, et al.
International Journal of Clinical Oncology|November 11, 2024
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resectionMasayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, et al.
Acta Neuropathologica Communications|October 1, 2024
Correction: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Japanese Journal of Clinical Oncology|September 3, 2024
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study groupKazuya Motomura, Keita Sasaki, Narushi Sugii, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Pageof 5